The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


Time/Date Code Headline Source Impact
07:00 24-May-2016 SLN Board Changes, Advisory Board and Notice of AGM RNS +7.84% Up
07:00 19-Apr-2016 SLN Director/PDMR Shareholding RNS +7.36% Up
18:09 18-Apr-2016 SLN Director/PDMR Shareholding RNS +6.97% Up
07:00 18-Apr-2016 SLN Grant of share options to Chief Executive RNS +6.97% Up
07:00 05-Apr-2016 SLN Atu027 Update RNS -0.16% Down
07:00 05-Apr-2016 SLN Final Results RNS -0.16% Down
07:00 30-Mar-2016 SLN Holding(s) in Company RNS +11.67% Up
07:00 22-Mar-2016 SLN Notice of Results RNS -1.85% Down
07:00 18-Jan-2016 SLN Board changes RNS -2.46% Down
07:00 12-Nov-2015 SLN Board appointment RNS -0.81% Down
14:32 30-Oct-2015 SLN Licensee's drug to commence Ph 2/Ph 3 trials RNS -8.90% Down
07:00 29-Sep-2015 SLN Interim Results RNS -8.82% Down
07:19 22-Sep-2015 SLN Board Change and Notice of Results RNS -0.16% Down
07:01 30-Jul-2015 SLN Interim Board Change RNS -3.21% Down
11:42 01-Jun-2015 SLN Result of AGM RNS -0.22% Down
07:00 01-Jun-2015 SLN AGM statement and clinical trial interim analysis RNS -0.22% Down

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address 1 Lyric Square, London, W6 0NB, United Kingdom
Company website http://www.silence-ther...
Market cap(in millions)* £ 88.65
Listing/Admission to trading 05 Jan 2010
Trading service SETS
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment AMSM
MiFID Status MTF
Exchange market size 1,500
ISIN number GB00B9GTXM62

SILENCE THER. share news analysis (SLN)